Evidence map›Paper›PMID 38394044›Full record

ArticleThe Libyan journal of medicine2024

Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia.

Abdulrhman S Elbnnani, Mohamed Elbasir, Salah Altabal, Yosra Lamami, Fawzi Ebrahim, Hakema M Oshah, Rasem Alagnef, Adam Elzagheid, Abdulmunem M Abulayha

Open access · goldAbstract read
In one paragraph

Article in The Libyan journal of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Abdulrhman S ElbnnaniDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Mohamed ElbasirDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Salah AltabalDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Yosra LamamiDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Fawzi EbrahimDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Hakema M OshahHigher Institute of Medical Technology, Misrata, Libya.
Rasem AlagnefTripoli Medical Center, Tripoli, Libya.
Adam ElzagheidDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Abdulmunem M AbulayhaDepartment of Human Cells and Tissues, Libyan Biotechnology Research Center, Tripoli, Libya.
Misurata University · LYUniversity of Tripoli · LY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of acute lymphoblastic leukemia (ALL), which is the most common type of cancer in children, has become more accurate with the use of flow cytometry. Here, this technology was used to immunophenotype leukemic cells in peripheral blood samples from Libyan pediatric ALL patients. We recruited 152 newly diagnosed patients at Tripoli Medical Center (Tripoli, Libya) by morphological examination of blood and bone marrow. Twenty-three surface and cytoplasmic antigen markers were used to characterize B and T cells in circulating blood cells by four-color flow cytometry. Six children (3.9%) turned out to have biphenotypic acute leukemia, 88 (57.9%) had B ALL, and 58 (38.1%) had T ALL. There were 68 cases of pro-B ALL CD10-positive (44.7%), 8 cases of pro-B ALL CD10-negative (5.2%), 6 cases of pre-B ALL (3.9%), and 6 of mature-B ALL (3.9%). CD13 was the most commonly expressed myeloid antigen in ALL. We present immunophenotypic data for the first time describing ALL cases in Libya. The reported results indicate that the most common subtype was pro-B ALL, and the frequency of T-ALL subtype was higher compared to previous studies. Six cases were positive for both myeloid and B lymphoid markers. Our findings may provide the basis for future studies to correlate immunophenotypic profile and genetic characteristics with treatment response among ALL patients.

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseChildFlow CytometryHumansImmunophenotypingLibyaacute leukemiaflow cytometryImmunophenotypic analysismonoclonal antibodypediatric patients

Identifiers

PMID38394044
PMCPMC10896131
OpenAlexW4392121681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.